🇺🇸 FDA
Patent

US 11584923

Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same

granted A61KA61K38/00A61K38/48

Quick answer

US patent 11584923 (Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same) held by HALOZYME, INC. expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
53
CPC classes
A61K, A61K38/00, A61K38/48, A61P, A61P19/04